Integrated Research Limited · ASX:IRI
Integrated Research — Shareholder Meeting (November 2023)
18 slides from Integrated Research's shareholder meeting presentation, Nov 22, 2023
Slide 1: Integrated Research Limited FY2023 Annual General Meeting
Integrated Research Limited (ASX: IRI) FY2023 Annual General Meeting 22 November 2023
Slide 2: How to ask a Question?
How to ask a Question? • To ask a written question select the Q & A icon • Select the topic your question relates to from the drop-down list • Type your question in the text box and press the send button • To ask a verbal question, follow the instructions below the broadcast window 2
Slide 3: How to Vote?
How to Vote? • When the poll is open, select the vote icon at the top of the screen Items of Business • To vote, select either For, Against or Abstain 2A Re-elect Mr Sam Sample as a Director FOR AGAINST ABSTAIN • You will see a vote confirmation 2B Re-elect Ms Jane Citizen as a Director • To change
Slide 4: Chair's Address
Chair’s Address Cathy Aston
Slide 5: CEO Address
CEO Address John Ruthven
Slide 6: We are IR
We are IR A leading global software company providing performance and experience management solutions for the world's mission critical ecosystems. Real-time analytics, fast troubleshooting, dynamic alerts, comprehensive reporting and customizable dashboards delivers a seamless user experience across
Slide 7: Blue Chip Customer Base
Blue Chip Customer Base Long-term, high value relationships based on mission critical solutions Tech | Telco BFSI Health | Gov | Edu Retail |Industrial | Other 5/20 largest Australian companies 5/10 top US telcos 7/10 top US banks 5/25 Fortune 500 top companies (market cap) 7
Slide 8: Full-Year Performance Review: Statutory (A$M)
Full-Year Performance Review: Statutory (A$M) Strong TCV growth drives statutory revenue 75.5 76.3 69.8 62.9 CASH RECEIPTS FROM REVENUE 11% CUSTOMERS 1% Jun-22 Jun-23 Jun-22 Jun-23 16.9 12.1 13.8 8.5 NET OPERATING EBITDA 42% CASHFLOW 18% Jun-22 Jun-23 Jun-22 Jun-23 18.6 2.6 9.3 1.5 NPAT (Excl impair
Slide 9: Full-Year Performance Review: Proforma (A$M)
Full-Year Performance Review: Proforma (A$M) TCV is a sales indicator, together with ARR, of the future direction of key proforma metrics 68.5 68.1 67.5 56.7 TOTAL CONTRACT ANNUAL RECURRING VALUE (TCV) 21% REVENUE 1 1% Jun-22 Jun-23 Jun-22 Jun-23 68.4 68.3 PROFORMA PROFORMA 24.5 17.6 SUBSCRIPTION RE
Slide 10: Balance Sheet
Balance Sheet Supporting self-funded organic growth Strong balance sheet with net cash of $18.6M and no Key Balance Sheet Metrics debt carried forward. Period Ended (as at) Jun 22 Jun 23 YoY A$M A$M Trade receivables: a strong Cash and cash equivalents 12.3 18.6 50% source of future cashflow. Trade
Slide 11: Product strategy
Product strategy Execution phase extended Phase II Phase I execution Phase III innovation new business scale new products grow market share Collaborate Transact and Infrastructure extend product target institutions converting customer solution focus on large enterprises suite to SWIFT ISO20022 stand
Slide 12: Collaborate – Strategy & Roadmap
Collaborate – Strategy & Roadmap Strategy Drivers Challenges Addressing challenges Customers – Customer success High single digit growth in Cloud-based vendors – GTM re-focused on – Renewal yield Collaboration market limiting API access to data large multi-vendor – Upsell seats customers & prospects
Slide 13: Collaborate Customer Wins
Collaborate Customer Wins Providing assurance for the mission critical services of our customers Multinational financial technology Cigna Healthcare (USA) Multinational technology and services company (USA) provider (USA) 2-year term 3-year term 3-year term New customer Renewal & expansion New custo
Slide 14: Transact & Infrastructure – Strategy & Roadmap
Transact & Infrastructure – Strategy & Roadmap Strategy Drivers Challenges Addressing challenges Customers – Customer success Double digit market Customer inertia - slow to Re-balanced GTM across – Renewal yield growth adopt new products customers and new – Upsell capacity prospects – Upsell new pro
Slide 15: Transact Customer Wins
Transact Customer Wins Ensuring reliability in today’s complex payments environments Network International LLC (MEA) Worldpay (USA) 3-year term 5-year term Renewal with major extension Renewal Solution: Transact and Infrastructure Solution: Transact and Infrastructure Challenge: Challenge: Expansion
Slide 16: FY24 Key Priorities
FY24 Key Priorities Markets – continue growth momentum across all regions New business – win more new business and expand product footprint Existing customers – improve customer retention and renewal yield Cost base – tightly manage to align with expected developments in the trading environment Prod
Slide 17: YTD Summary Report
YTD Summary Report Priority Status Notes Markets – continue growth momentum across all on plan YTD TCV is ahead of pcp, and customer sentiment regions appears to have normalised. TCV growth expected for the full year. New business – win more new business and expand on plan YTD we have won 9 new cust
Slide 18: Disclaimer
Disclaimer SUMMARY INFORMATION FORWARD LOOKING STATEMENTS NOT AN OFFER This document and the associated transcript (together “the presentation”) has The presentation contains certain "forward-looking statements”. The words The presentation is for information purposes only and is not a prospectus, be
Integrated Research — Shareholder Meeting (November 2023) on 6ix